We are live on ! Find out more
KFP

Keystone Financial Planning Portfolio holdings

AUM $388M
1-Year Est. Return 16.66%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+16.66%
3 Year Est. Return
+34.06%
5 Year Est. Return
+32.93%
10 Year Est. Return
+97.12%
AUM
$294M
AUM Growth
+$18.5M
Cap. Flow
-$4.74M
Cap. Flow %
-1.61%
Top 10 Hldgs %
56.05%
Holding
46
New
1
Increased
10
Reduced
28
Closed
–

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.87M
2
AMGN icon
Amgen
AMGN
+$6.78M
3
KMB icon
Kimberly-Clark
KMB
+$6.15M
4
VZ icon
Verizon
VZ
+$1.07M
5
LMT icon
Lockheed Martin
LMT
+$818K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.75M
2
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$8.72M
3
BEN icon
Franklin Resources
BEN
+$7.16M
4
IBM icon
IBM
IBM
+$922K
5
USB icon
US Bancorp
USB
+$568K

Sector Composition

Rank Sector Weight
1 Consumer Staples 17.76%
2 Healthcare 13.97%
3 Technology 9.09%
4 Utilities 7.57%
5 Energy 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHD icon
1
Schwab US Dividend Equity ETF
SCHD
$100B
$81.4M 27.74%
3,022,308
-335,565
-10% -$8.72M
GSK icon
2
GSK
GSK
$101B
$10.3M 3.51%
186,683
-3,470
-2% -$181K
XOM icon
3
ExxonMobil
XOM
$650B
$10.2M 3.46%
166,014
-5,138
-3% -$321K
HDV
4
iShares Core High Dividend ETF
HDV
$14.2B
$10.1M 3.43%
497,835
+2,960
+0.6% +$58K
MSFT icon
5
Microsoft
MSFT
$2.88T
$9.97M 3.4%
29,653
-414
-1% -$134K
CVX icon
6
Chevron
CVX
$392B
$9.76M 3.32%
83,147
-3,108
-4% -$353K
VZ icon
7
Verizon
VZ
$185B
$8.95M 3.05%
172,282
+20,443
+13% +$1.07M
PM icon
8
Philip Morris
PM
$300B
$8.44M 2.87%
88,794
-1,148
-1% -$107K
IBM icon
9
IBM
IBM
$189B
$7.83M 2.67%
58,559
-7,353
-11% -$922K
AMGN icon
10
Amgen
AMGN
$196B
$7.68M 2.62%
34,140
+32,113
+1,584% +$6.78M
NJR icon
11
New Jersey Resources
NJR
$5.89B
$7.52M 2.56%
183,084
-2,628
-1% -$102K
BMY icon
12
Bristol-Myers Squibb
BMY
$124B
$7.3M 2.49%
+117,124
New +$6.87M
AEP icon
13
American Electric Power
AEP
$72.6B
$7.23M 2.46%
81,281
+5,279
+7% +$445K
GIS icon
14
General Mills
GIS
$19.3B
$7.15M 2.43%
106,056
-2,106
-2% -$134K
T icon
15
AT&T
T
$158B
$7.14M 2.43%
384,377
-13,118
-3% -$245K
MRK icon
16
Merck
MRK
$319B
$7.12M 2.43%
92,950
+2,968
+3% +$236K
BTI icon
17
British American Tobacco
BTI
$130B
$6.92M 2.36%
184,835
-2,411
-1% -$85.6K
KMB icon
18
Kimberly-Clark
KMB
$35.5B
$6.91M 2.35%
48,332
+45,677
+1,720% +$6.15M
UL icon
19
Unilever
UL
$130B
$6.73M 2.29%
111,192
+11,876
+12% +$705K
K
20
DELISTED
Kellanova
K
$6.59M 2.24%
108,892
+2,653
+2% +$157K
PNW icon
21
Pinnacle West Capital
PNW
$12.9B
$6.46M 2.2%
91,477
-1,770
-2% -$119K
MO icon
22
Altria Group
MO
$120B
$5.48M 1.87%
115,630
-1,617
-1% -$74.1K
QCOM icon
23
Qualcomm
QCOM
$182B
$5.22M 1.78%
28,560
-466
-2% -$74.6K
MMM icon
24
3M
MMM
$87.2B
$4.04M 1.38%
27,185
+5,258
+24% +$783K
BEN icon
25
Franklin Resources
BEN
$16.8B
$3.88M 1.32%
115,801
-217,539
-65% -$7.16M
1
2

Similar funds

RWM
Ruedi Wealth Management Champaign, Illinois $388M AUM 14.69% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return
AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WA
WP Advisors San Francisco, California $387M AUM 21.17% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

Keystone Financial Planning's Q4 2021 Portfolio in Review

As of Q4 2021, Keystone Financial Planning held 46 positions worth $294M, up 6.7% from $275M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 2.2%. Keystone Financial Planning opened 1 new position and made no exits, leaving the 46-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Keystone Financial Planning's largest Q4 2021 buy was Bristol-Myers Squibb: 117,124 shares worth $7.3M.
  • Keystone Financial Planning added most to Amgen in Q4 2021, an estimated $6.78M increase.
  • Keystone Financial Planning's biggest Q4 2021 reduction was Pfizer, cutting an estimated $8.75M.
  • Keystone Financial Planning's ten largest holdings make up 56% of its $294M portfolio in Q4 2021.
  • Keystone Financial Planning opened 1 new position and closed 0 in Q4 2021.
  • Keystone Financial Planning's portfolio value rose 6.7% quarter-over-quarter to $294M.

Based on Keystone Financial Planning's 13F filing for Q4 2021, filed 9 Feb 2022.